113 related articles for article (PubMed ID: 1462293)
1. [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Wilhelmsen I; Hundal O; Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1992 Oct; 112(25):3197-9. PubMed ID: 1462293
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
[TBL] [Abstract][Full Text] [Related]
3. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
4. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
6. [10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
Berstad A; Berstad K; Hatlebakk JG; Wilhelmsen I; Nysaeter G; Bang CJ; Hausken T; Nesje LB; Hjartholm AS; Hundal O
Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2477-9. PubMed ID: 7940447
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
8. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
[TBL] [Abstract][Full Text] [Related]
9. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
[TBL] [Abstract][Full Text] [Related]
10. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Iser JH; Buttigieg RJ; Iseli A
Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
[TBL] [Abstract][Full Text] [Related]
11. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Sung JJ; Leung VK; Chung SC; Ling TK; Suen R; Cheng AF; Li AK
Am J Gastroenterol; 1995 Sep; 90(9):1424-7. PubMed ID: 7661162
[TBL] [Abstract][Full Text] [Related]
12. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
14. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
[TBL] [Abstract][Full Text] [Related]
16. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Rosengren H; Polson RJ
Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
[TBL] [Abstract][Full Text] [Related]
17. Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Coelho LG; Passos MC; Chausson Y; Castro Lde P
Am J Gastroenterol; 1991 Aug; 86(8):971-5. PubMed ID: 1858763
[TBL] [Abstract][Full Text] [Related]
18. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
